Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINESSE-CKD
NCT07819227Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2025
- Primary completion
- Aug 2026
- Countries
- 4
01
Overview
A Phase 2 trial of finerenone, semaglutide in chronic kidney disease (CKD), sponsored by University Medical Center Groningen. Started Feb 2025; status: completed.
02
Drugs
finerenonesemaglutide
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07819227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07819227.